THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 125 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,961,599 | +78458.2% | 227,300 | -1.2% | 0.08% | -12.0% |
| Q1 2023 | $2,497 | +19.5% | 230,100 | +23.5% | 0.09% | +58.6% |
| Q4 2022 | $2,090 | -99.9% | 186,300 | -17.2% | 0.06% | +81.2% |
| Q3 2022 | $2,282,000 | -73.3% | 225,000 | -61.7% | 0.03% | -86.5% |
| Q2 2021 | $8,533,000 | +3272.7% | 587,666 | +7841.4% | 0.24% | +5825.0% |
| Q3 2017 | $253,000 | -57.1% | 7,400 | -79.4% | 0.00% | -20.0% |
| Q4 2015 | $590,000 | +44.3% | 35,952 | +52.5% | 0.01% | -16.7% |
| Q1 2015 | $409,000 | -52.6% | 23,568 | -59.2% | 0.01% | -45.5% |
| Q4 2014 | $862,000 | – | 57,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |